EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model

Mohammad Majd Hammour iD, Lisa Herzberger, Yuxuan Xin iD, Guanqiao Chen iD, Melike Tombaz iD, Sabrina Ehnert iD, Fabian Springer, Georg Damm iD, Massoud Vosough iD, Jan G Hengstler iD, Ursula Müller-Vieira, Andreas K Nüssler iD und 1 weitere

Archives of Toxicology · 2026-09 · 100 (9) · 4151-4169

DOI: 10.1007/s00204-026-04431-x ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Toxicology, online erschienen am 13.05.2026. Verfasst von Mohammad Majd Hammour und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Traumatology, Siegfried Weller Institute, BG Clinic Tübingen, Eberhard Karls University, 72076, Tübingen, Germany. Hauptthemen laut MEDLINE: Vitamin D, Liver, Fatty Acids, Nonesterified, Bone and Bones. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universitätsklinikum Tübingen.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Metabolic dysfunction-associated steatotic liver disease (MASLD) is a systemic condition associated with compromised bone integrity. Emerging evidence suggests that disturbances in hepatic vitamin D metabolism may contribute to these skeletal impairments. However, the hepatic mechanisms driving bone deterioration remain poorly defined. This study aimed to establish a human 3D in vitro model of MASLD and demonstrate that hepatic vitamin D dysregulation adversely affects bone homeostasis. Liver spheroids composed of HepaRG cells, LX-2 stellate cells, and HUVECs were stimulated with 600 µM free fatty acids (2:1 oleic: palmitic acid) to induce MASLD-like features, validated by BODIPY staining and gene expression. MASLD model induction led to downregulation of hepatic genes regulating lipid and vitamin D metabolism. ELISA confirmed significantly reduced 25-hydroxyvitamin D levels, aligning with downregulation of CYP2R1 and CYP27A1 . Transcriptomic profiling of human MASLD liver biopsies validated these molecular changes. To evaluate MASLD’s systemic impact on bone, THP-1-derived macrophages and SCP-1 mesenchymal stem cells were seeded onto bone scaffolds and co-cultured with spheroids. Bone scaffolds co-cultured with MASLD spheroids showed impaired mineralization and elevated expression of bone resorption markers. These findings mirror skeletal dysfunction observed in MASLD patients and suggest a mechanistic link between hepatic vitamin D dysregulation and bone pathology. This study introduces a pioneering 3D human liver-bone co-culture model that reveals MASLD-driven disruption of hepatic vitamin D metabolism as a direct contributor to bone deterioration. This 3D model develops a powerful translational platform for decoding systemic disease mechanisms and targeting the liver-bone axis therapeutically.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vitamin DLiverFatty Acids, NonesterifiedBone and BonesHumansHomeostasisCholestanetriol 26-MonooxygenaseCytochrome P450 Family 2Spheroids, CellularCoculture Techniques

Stichwörter der Autor:innen

In vitro modelLiver spheroidsMASLDMetabolic activityVitamin Done health

Substanzen

Vitamin DFatty Acids, NonesterifiedCholestanetriol 26-Monooxygenase25-hydroxyvitamin DCYP27A1 protein, humanCYP2R1 protein, humanCytochrome P450 Family 2

Autor:innen und Institutionen

  • Department of Traumatology, Siegfried Weller Institute, BG Clinic Tübingen, Eberhard Karls University, 72076, Tübingen, Germany.
  • Boehringer Ingelheim Pharma GmbH & Co. KG, NCE, Biberach an der Riss, Germany.
  • Department of Diagnostic and Interventional Radiology, University Hospital Tübingen, Hoppe- Seyler-Str. 3, 72076, Tübingen, Germany.
  • Department of Radiology, BG-Klinik Tübingen, Eberhard Karls University, 72076, Tübingen, Germany.
  • Department of Hepatobiliary Surgery and Visceral Transplantation, Thoracic and Vascular Surgery, Clinic for Visceral, Leipzig University Medical Center, 04103, Transplant, Leipzig, Germany.
  • Department of Regenerative Medicine, Cell Science Research Center, Royan Institute for Stem Cell Biology and Technology, ACECR, Tehran, Iran.

ORCID-Profile: Mohammad Majd Hammour, Yuxuan Xin, Guanqiao Chen, Melike Tombaz, Sabrina Ehnert, Georg Damm, Massoud Vosough, Jan G Hengstler, Andreas K Nüssler, Romina H Aspera-Werz

Förderung

  • Universitätsklinikum Tübingen

Zitieren

APA

Hammour, M. M., Herzberger, L., Xin, Y., Chen, G., Tombaz, M., Ehnert, S., Springer, F., Damm, G., Vosough, M., Hengstler, J. G., Müller-Vieira, U., Nüssler, A. K., & Aspera-Werz, R. H. (2026). Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model. Archives of Toxicology, 100(9), 4151-4169. https://doi.org/10.1007/s00204-026-04431-x

Vancouver

Hammour MM, Herzberger L, Xin Y, Chen G, Tombaz M, Ehnert S, et al. Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model. Archives of Toxicology. 2026;100(9):4151-4169. doi:10.1007/s00204-026-04431-x

BibTeX
@article{Hammour2026,
  author = {Hammour, Mohammad Majd and Herzberger, Lisa and Xin, Yuxuan and Chen, Guanqiao and Tombaz, Melike and Ehnert, Sabrina and Springer, Fabian and Damm, Georg and Vosough, Massoud and Hengstler, Jan G and Müller-Vieira, Ursula and Nüssler, Andreas K and Aspera-Werz, Romina H},
  title = {Free Fatty acid-induced disruption of hepatic vitamin D metabolism impairs bone homeostasis in an in vitro 3D human liver–bone model},
  journal = {Archives of Toxicology},
  year = {2026},
  volume = {100},
  number = {9},
  pages = {4151--4169},
  doi = {10.1007/s00204-026-04431-x}
}
Kostenlos starten →